Skip to content

Research at St Andrews

Translational research will fail without surgical leadership: SCOTRRCC a successful surgeon-led Nationwide translational research infrastructure in renal cancer

Research output: Contribution to journalArticle


G.D. Stewart, A.C.P. Riddick, F. Rae, C. Marshall, L. MacLeod, F.C. O'Mahony, A. Laird, S. Alan McNeill, K.M. O'Connor, M. O'Donnell, P. Fineron, D.B. McLaren, M. Aitchison, G. Oades, J. Hair, M. Seywright, B. Little, R. Nairn, G. Lamb, T. Macleod & 9 more I. Dunn, A. Ramsey, R. Campbell, S. Leung, L. McLornan, M. Rahilly, I. Wilson, A.-M. Pollock, D.J. Harrison

School/Research organisations


Background: High quality human biosamples with associated high quality clinical data are essential for successful translational research. Despite this, the traditional approach is for the surgeon to act as a technician in the tissue collection act. Biomarker research presents multiple challenges and the field is littered with failures. Tissue quality, poor clinical information, small sample numbers and lack of validation cohorts are just a few reasons for failure. It is clear that the surgeon involved in tissue acquisition must be fully engaged in the process of biosampling for a specific condition, as this will negate many of the issues for translational research failure due to an inadequate bioresource. Approach: In this Matter for Debate paper, the Scottish Collaboration On Translational Research into Renal Cell Cancer (SCOTRRCC) is discussed as an example of a urological surgery lead bioresource which has resulted in a National collection of renal cancer tissue and blood (from over 900 patients to date), negating all of the traditional issues with biobanks because of close enagagement and acknowledgement of urologists and uropathologists from seven centres around Scotland. SCOTRRCC has leveraged renal cancer research in Scotland resulting in several high impact publications and providing a springboard for future research in this disease in Scotland and beyond. Conclusions: The SCOTRRCC model presented here can be transferred to other surgical disciplines for success in translational research.


Original languageEnglish
Early online date30 Apr 2015
Publication statusPublished - 2015

    Research areas

  • Surgeon-led, Translational research, Nationwide, Renal Cancer

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Distribution of glutathione S-transferase isoenzymes in human ovary

    Rahilly, M., Carder, P. J., Al-Nafussi, A. & Harrison, D. J., Nov 1991, In : Journal of Reproduction and Fertility. 93, 2, p. 303-311 9 p.

    Research output: Contribution to journalArticle

  2. Glutathione S-transferase detoxication enzymes in cervical neoplasia

    Carder, P. J., al-Nafussi, A., Rahilly, M., Lauder, J. & Harrison, D. J., Dec 1990, In : Journal of Pathology. 162, 4, p. 303-308 6 p.

    Research output: Contribution to journalArticle

  3. Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models

    Langdon, S. P., Kay, C., Um, I. H., Muir, M., Sellar, G., Kan, J., Gourley, C. & Harrison, D. J., 10 Dec 2019, In : Scientific Reports. 9, 9 p., 18742.

    Research output: Contribution to journalArticle

  4. The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome

    Ried, T., Meijer, G. A., Harrison, D. J., Grech, G., Franch-Expósito, S., Briffa, R., Carvalho, B. & Camps, J., Oct 2019, In : Molecular Aspects of Medicine. 69, p. 48-61 14 p.

    Research output: Contribution to journalArticle

Related by journal

ID: 188963610